Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
NYU's Ambulatory Care Center at 240 East 38th Street, New York, NY, USA
We will be having a joint session with another community group, the alopecia areata group. Alopecia areata is an immune-related disease, like vitiligo, that causes hair loss usually in patches on the scalp and eyebrows.
The meeting will be on:
Thursday, April 13th, 2017 at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Avenues!
Note that as of now, the meeting time has been changed from 6:30 to 7PM
Spread the word and all family and friends are welcome!
Please let us know if you will be able to attend by email firstname.lastname@example.org.
We look forward to seeing you all there.
NY Vitiligo Community
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems. For more than 1.6 million peop...
- Can a gluten-free diet help with vitiligo?
It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...
- Who is prone to vitiligo?
Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.